Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Attitudes toward prenatal screening for chromosomal abnormalities: A focus group study.

Munro S, Sou J, Zhang W, Mohammadi T, Trenaman L, Langlois S, Anis AH.

Women Birth. 2018 Sep 27. pii: S1871-5192(18)30359-7. doi: 10.1016/j.wombi.2018.09.006. [Epub ahead of print]

PMID:
30270016
2.

Cost Savings Analysis of Early Extubation Following Congenital Heart Surgery.

Holowachuk S, Zhang W, Gandhi SK, Anis AH, Potts JE, Harris KC.

Pediatr Cardiol. 2018 Sep 10. doi: 10.1007/s00246-018-1970-0. [Epub ahead of print]

PMID:
30203291
3.

Output from the CIHR Canadian HIV Trials Network international postdoctoral fellowship for capacity building in HIV clinical trials.

Mbuagbaw L, Slogrove AL, Sas J, Lengwe Kunda J, Morfaw F, Mukonzo JK, Cao W, Ngomba-Kadima G, Zunza M, Ongolo-Zogo P, Nana PN, Cockcroft A, Andersson N, Sewankambo N, Cotton MF, Li T, Young T, Singer J, Routy JP, Ross CJ, Thin K, Thabane L, Anis AH.

HIV AIDS (Auckl). 2018 Aug 16;10:151-155. doi: 10.2147/HIV.S150107. eCollection 2018.

4.

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder.

Palis H, Marchand K, Karamouzian M, MacDonald S, Harrison S, Guh D, Lock K, Brissette S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Addict Behav Rep. 2018 Mar 27;7:82-89. doi: 10.1016/j.abrep.2018.03.005. eCollection 2018 Jun.

5.

Influenza vaccination for HIV-positive people: Systematic review and network meta-analysis.

Zhang W, Sun H, Atiquzzaman M, Sou J, Anis AH, Cooper C.

Vaccine. 2018 Jun 27;36(28):4077-4086. doi: 10.1016/j.vaccine.2018.05.077. Epub 2018 May 30. Review.

PMID:
29859802
6.

The design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British Columbia.

Brunham LR, Lynch K, English A, Sutherland R, Weng J, Cho R, Wong GC, Anis AH, Francis GA, Khan NA, McManus B, Wood D, Walley KR, Leipsic J, Humphries KH, Hoens A, Krahn AD, John Mancini GB, Pimstone S.

Clin Cardiol. 2018 Jul;41(7):888-895. doi: 10.1002/clc.22959. Epub 2018 Jun 11.

7.

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.

Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH.

Addiction. 2018 Jul;113(7):1264-1273. doi: 10.1111/add.14171. Epub 2018 Mar 28.

PMID:
29589873
8.

Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis.

Bansback N, Fu E, Sun H, Guh D, Zhang W, Lacaille D, Milbers K, Anis AH.

Curr Rheumatol Rep. 2017 Sep;19(9):54. doi: 10.1007/s11926-017-0680-6. Review.

PMID:
28752490
9.

Adherence to Antitumor Necrosis Factor Use Recommendations in Spondyloarthritis: Measurement and Effect in the DESIR Cohort.

Harvard S, Guh D, Bansback N, Richette P, Saraux A, Fautrel B, Anis AH.

J Rheumatol. 2017 Oct;44(10):1436-1444. doi: 10.3899/jrheum.161399. Epub 2017 Jul 1.

PMID:
28668809
10.

Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.

Joyce VR, Sun H, Barnett PG, Bansback N, Griffin SC, Bayoumi AM, Anis AH, Sculpher M, Cameron W, Brown ST, Holodniy M, Owens DK.

MDM Policy Pract. 2017 Jul 3;2(2):2381468317716440. doi: 10.1177/2381468317716440. eCollection 2017 Jul-Dec.

11.

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.

Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT.

Drug Alcohol Rev. 2018 Jan;37(1):137-146. doi: 10.1111/dar.12573. Epub 2017 Jun 8.

PMID:
28593748
12.

Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

Bansback N, Phibbs CS, Sun H, O'Dell JR, Brophy M, Keystone EC, Leatherman S, Mikuls TR, Anis AH; CSP 551 RACAT Investigators.

Ann Intern Med. 2017 Jul 4;167(1):8-16. doi: 10.7326/M16-0713. Epub 2017 May 30.

PMID:
28554192
13.

Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.

Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Subst Abuse Treat Prev Policy. 2017 May 19;12(1):25. doi: 10.1186/s13011-017-0110-9.

14.

Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.

Oviedo-Joekes E, Brissette S, MacDonald S, Guh D, Marchand K, Jutha S, Harrison S, Janmohamed A, Zhang DZ, Anis AH, Krausz M, Marsh DC, Schechter MT.

Drug Alcohol Depend. 2017 Jul 1;176:55-62. doi: 10.1016/j.drugalcdep.2017.02.021. Epub 2017 May 10.

PMID:
28521199
15.

A Practical ANOVA Approach for Uncertainty Analysis in Population-Based Disease Microsimulation Models.

Sharif B, Wong H, Anis AH, Kopec JA.

Value Health. 2017 Apr;20(4):710-717. doi: 10.1016/j.jval.2017.01.002. Epub 2017 Mar 11.

16.

Validation of Administrative Osteoarthritis Diagnosis Using a Clinical and Radiological Population-Based Cohort.

Rahman MM, Kopec JA, Goldsmith CH, Anis AH, Cibere J.

Int J Rheumatol. 2016;2016:6475318. doi: 10.1155/2016/6475318. Epub 2016 Dec 29.

17.

Valuing productivity loss due to absenteeism: firm-level evidence from a Canadian linked employer-employee survey.

Zhang W, Sun H, Woodcock S, Anis AH.

Health Econ Rev. 2017 Dec;7(1):3. doi: 10.1186/s13561-016-0138-y. Epub 2017 Jan 19.

18.

The impact of price-cap regulations on market entry by generic pharmaceutical firms.

Zhang W, Sun H, Guh D, Anis AH.

Expert Rev Pharmacoecon Outcomes Res. 2017 Apr;17(2):231-238. doi: 10.1080/14737167.2017.1271717. Epub 2016 Dec 27.

PMID:
27936981
19.

Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study.

Zhang W, Bansback N, Sun H, Pedersen R, Kotak S, Anis AH.

RMD Open. 2016 Jul 7;2(2):e000222. doi: 10.1136/rmdopen-2015-000222. eCollection 2016.

20.

Incentives in Rheumatology: the Potential Contribution of Physician Responses to Financial Incentives, Public Reporting, and Treatment Guidelines to Health Care Sustainability.

Harrison M, Milbers K, Mihic T, Anis AH.

Curr Rheumatol Rep. 2016 Jul;18(7):42. doi: 10.1007/s11926-016-0596-6. Review.

PMID:
27240436
21.

The Impact of Price-cap Regulations on Exit by Generic Pharmaceutical Firms.

Zhang W, Guh D, Sun H, Marra CA, Lynd LD, Anis AH.

Med Care. 2016 Sep;54(9):884-90. doi: 10.1097/MLR.0000000000000577.

PMID:
27213540
22.

Distribution and Drivers of Average Direct Cost of Osteoarthritis in Canada From 2003 to 2010.

Sharif B, Kopec JA, Wong H, Anis AH.

Arthritis Care Res (Hoboken). 2017 Feb;69(2):243-251. doi: 10.1002/acr.22933.

23.

Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.

Oviedo-Joekes E, Guh D, Brissette S, Marchand K, MacDonald S, Lock K, Harrison S, Janmohamed A, Anis AH, Krausz M, Marsh DC, Schechter MT.

JAMA Psychiatry. 2016 May 1;73(5):447-55. doi: 10.1001/jamapsychiatry.2016.0109.

PMID:
27049826
24.

Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study.

Zhang W, Bansback N, Sun H, Pedersen R, Kotak S, Anis AH.

RMD Open. 2015 Apr 8;1(1):e000042. doi: 10.1136/rmdopen-2014-000042. eCollection 2015.

25.

Multiattribute health utility scoring for the computerized adaptive measure CAT-5D-QOL was developed and validated.

Kopec JA, Sayre EC, Rogers P, Davis AM, Badley EM, Anis AH, Abrahamowicz M, Russell L, Rahman MM, Esdaile JM.

J Clin Epidemiol. 2015 Oct;68(10):1213-20.e1-6. doi: 10.1016/j.jclinepi.2015.03.020. Epub 2015 Apr 14.

PMID:
25990544
26.

Risk of Type 2 Diabetes among Osteoarthritis Patients in a Prospective Longitudinal Study.

Rahman MM, Cibere J, Anis AH, Goldsmith CH, Kopec JA.

Int J Rheumatol. 2014;2014:620920. doi: 10.1155/2014/620920. Epub 2014 Nov 4.

27.

Systematic review of cost-effectiveness analyses of treatments for psoriasis.

Zhang W, Islam N, Ma C, Anis AH.

Pharmacoeconomics. 2015 Apr;33(4):327-40. doi: 10.1007/s40273-014-0244-9. Review.

PMID:
25475964
28.

Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.

Oviedo-Joekes E, Sordo L, Guh D, Marsh DC, Lock K, Brissette S, Anis AH, Schechter MT.

Addict Behav. 2015 Feb;41:81-6. doi: 10.1016/j.addbeh.2014.10.003. Epub 2014 Oct 7.

29.

Effect of management strategies and clinical status on costs of care for advanced HIV.

Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin SC, Sun H, Holodniy M, Brown ST, Cameron W, Sculpher M, Youle M, Anis AH, Owens DK.

Am J Manag Care. 2014 May;20(5):e129-37.

PMID:
25326927
30.

A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial.

Oviedo-Joekes E, Marchand K, Lock K, Chettiar J, Marsh DC, Brissette S, Anis AH, Schechter MT.

Addict Sci Clin Pract. 2014 Sep 29;9:21. doi: 10.1186/1940-0640-9-21.

31.

Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population.

Linder A, Guh D, Boyd JH, Walley KR, Anis AH, Russell JA.

Crit Care Med. 2014 Oct;42(10):2211-8. doi: 10.1097/CCM.0000000000000503.

PMID:
25054672
32.

Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment.

Oviedo-Joekes E, Guh D, Marchand K, Marsh DC, Lock K, Brissette S, Anis AH, Schechter MT.

Subst Abuse Treat Prev Policy. 2014 Jun 8;9:23. doi: 10.1186/1747-597X-9-23.

33.

Osteoarthritis incidence and trends in administrative health records from British Columbia, Canada.

Rahman MM, Cibere J, Goldsmith CH, Anis AH, Kopec JA.

J Rheumatol. 2014 Jun;41(6):1147-54. doi: 10.3899/jrheum.131011. Epub 2014 Apr 15.

PMID:
24737915
34.

High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study.

Nosyk B, Fischer B, Sun H, Marsh DC, Kerr T, Rehm JT, Anis AH.

Am J Addict. 2014 May-Jun;23(3):257-64. doi: 10.1111/j.1521-0391.2014.12091.x.

35.

Health-related productivity loss: NICE to recognize soon, good to discuss now.

Zhang W, Anis AH.

Pharmacoeconomics. 2014 May;32(5):425-7. doi: 10.1007/s40273-014-0149-7. No abstract available.

PMID:
24639039
36.

Optimal timing of influenza vaccination in patients with human immunodeficiency virus: a Markov cohort model based on serial study participant hemoagglutination inhibition titers.

Werker GR, Sharif B, Sun H, Cooper C, Bansback N, Anis AH.

Vaccine. 2014 Feb 3;32(6):677-84. doi: 10.1016/j.vaccine.2013.11.103. Epub 2013 Dec 16.

PMID:
24355089
37.
38.

Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.

Bayoumi AM, Barnett PG, Joyce VR, Griffin SC, Sun H, Bansback NJ, Holodniy M, Sanders G, Brown ST, Kyriakides TC, Angus B, Cameron DW, Anis AH, Sculpher M, Owens DK.

J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):382-91. doi: 10.1097/QAI.0000000000000002.

39.

Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study.

Rahman MM, Kopec JA, Anis AH, Cibere J, Goldsmith CH.

Arthritis Care Res (Hoboken). 2013 Dec;65(12):1951-8. doi: 10.1002/acr.22092.

40.

Therapies for active rheumatoid arthritis after methotrexate failure.

O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E; CSP 551 RACAT Investigators.

N Engl J Med. 2013 Jul 25;369(4):307-18. doi: 10.1056/NEJMoa1303006. Epub 2013 Jun 11.

41.

The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study.

Rahman MM, Kopec JA, Cibere J, Goldsmith CH, Anis AH.

BMJ Open. 2013 May 14;3(5). pii: e002624. doi: 10.1136/bmjopen-2013-002624.

42.

An update on the measurement of productivity losses due to rheumatoid diseases.

Zhang W, Chiu JA, Bansback N, Anis AH.

Best Pract Res Clin Rheumatol. 2012 Oct;26(5):585-97. doi: 10.1016/j.berh.2012.08.008. Review.

PMID:
23218424
43.

The effect of direct-to-consumer genetic tests on anticipated affect and health-seeking behaviors: a pilot survey.

Bansback N, Sizto S, Guh D, Anis AH.

Genet Test Mol Biomarkers. 2012 Oct;16(10):1165-71. doi: 10.1089/gtmb.2012.0074. Epub 2012 Aug 29.

PMID:
22931244
44.

Risk of gastrointestinal events in patients with rheumatoid arthritis after withdrawal of rofecoxib.

Marra CA, Lynd LD, Colley L, Harvard SS, Lacaille D, Schwenger E, Anis AH, Esdaile JM.

J Rheumatol. 2012 May;39(5):910-5. doi: 10.3899/jrheum.110604. Epub 2012 Mar 15.

PMID:
22422500
45.

Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.

Nosyk B, Guh DP, Bansback NJ, Oviedo-Joekes E, Brissette S, Marsh DC, Meikleham E, Schechter MT, Anis AH.

CMAJ. 2012 Apr 3;184(6):E317-28. doi: 10.1503/cmaj.110669. Epub 2012 Mar 12.

46.

Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study.

Nosyk B, Sun H, Evans E, Marsh DC, Anglin MD, Hser YI, Anis AH.

Addiction. 2012 Sep;107(9):1621-9. doi: 10.1111/j.1360-0443.2012.03870.x. Epub 2012 May 8.

47.

Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis.

Zhang W, Bansback N, Boonen A, Severens JL, Anis AH.

Value Health. 2012 Jan;15(1):46-54. doi: 10.1016/j.jval.2011.07.009. Epub 2011 Oct 1.

48.

The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.

Nosyk B, Sharif B, Sun H, Cooper C, Anis AH; CIHR Canadian HIV Trials Network Influenza Vaccine Research Group.

PLoS One. 2011;6(12):e27059. doi: 10.1371/journal.pone.0027059. Epub 2011 Dec 6.

49.

Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment.

Guo N, Marra CA, FitzGerald JM, Elwood RK, Anis AH, Marra F.

Value Health. 2011 Sep-Oct;14(6):937-43. doi: 10.1016/j.jval.2011.05.003. Epub 2011 Jul 29.

50.

The cost of fall related presentations to the ED: a prospective, in-person, patient-tracking analysis of health resource utilization.

Woolcott JC, Khan KM, Mitrovic S, Anis AH, Marra CA.

Osteoporos Int. 2012 May;23(5):1513-9. doi: 10.1007/s00198-011-1764-1. Epub 2011 Sep 3.

PMID:
21892675

Supplemental Content

Support Center